67 related articles for article (PubMed ID: 21756326)
1. An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
Noske A; Schwabe M; Weichert W; Darb-Esfahani S; Buckendahl AC; Sehouli J; Braicu EI; Budczies J; Dietel M; Denkert C
BMC Cancer; 2011 Jul; 11():294. PubMed ID: 21756326
[TBL] [Abstract][Full Text] [Related]
2. Activated epidermal growth factor receptor in ovarian cancer.
Hudson LG; Zeineldin R; Silberberg M; Stack MS
Cancer Treat Res; 2009; 149():203-26. PubMed ID: 19763438
[No Abstract] [Full Text] [Related]
3. Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging.
Zhang F; Wang S; Yin L; Yang Y; Guan Y; Wang W; Xu H; Tao N
Anal Chem; 2015 Oct; 87(19):9960-5. PubMed ID: 26368334
[TBL] [Abstract][Full Text] [Related]
4. EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma.
Vo D; Liu Y; Sood AK; Rezvani K; Jazaeri AA; Liu J
Cancer Biomark; 2024; 39(4):289-298. PubMed ID: 38250760
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract][Full Text] [Related]
6. HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma.
McNamara B; Mutlu L; Greenman M; Harold J; Santin A
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627113
[TBL] [Abstract][Full Text] [Related]
7. p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair.
Mak VC; Li X; Rao L; Zhou Y; Tsao SW; Cheung LW
Neoplasia; 2021 Jul; 23(7):718-730. PubMed ID: 34144267
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of HER-2/neu Gene Amplification in Epithelial Ovarian Carcinoma.
Pankaj S; Kumari J; Choudhary V; Kumari A; Kumari S; Kumari A; Nazneen S; Madhawi R; Kumar S
J Obstet Gynaecol India; 2019 Oct; 69(Suppl 2):177-181. PubMed ID: 31686753
[TBL] [Abstract][Full Text] [Related]
9. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome.
Yan G; Saeed MEM; Foersch S; Schneider J; Roth W; Efferth T
Oncotarget; 2019 Mar; 10(20):1918-1931. PubMed ID: 30956774
[TBL] [Abstract][Full Text] [Related]
10. EGFR Immunoexpression in Malignant Serous and Mucinous Ovarian Tumors.
Cîrstea AE; Stepan AE; Zăvoi RE; Simionescu CE
Curr Health Sci J; 2018; 44(2):129-134. PubMed ID: 30746159
[TBL] [Abstract][Full Text] [Related]
11. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
Heublein S; Page S; Mayr D; Schmoeckel E; Trillsch F; Marmé F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642093
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting cancer cell hallmark features through nuclear export inhibition.
Sun Q; Chen X; Zhou Q; Burstein E; Yang S; Jia D
Signal Transduct Target Ther; 2016; 1():16010. PubMed ID: 29263896
[TBL] [Abstract][Full Text] [Related]
13. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review.
Mehner C; Oberg AL; Goergen KM; Kalli KR; Maurer MJ; Nassar A; Goode EL; Keeney GL; Jatoi A; Radisky DC; Radisky ES
Genes Cancer; 2017 May; 8(5-6):589-599. PubMed ID: 28740577
[TBL] [Abstract][Full Text] [Related]
14. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression.
Menderes G; Bonazzoli E; Bellone S; Altwerger G; Black JD; Dugan K; Pettinella F; Masserdotti A; Riccio F; Bianchi A; Zammataro L; de Haydu C; Buza N; Hui P; Wong S; Huang GS; Litkouhi B; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2017 Oct; 147(1):145-152. PubMed ID: 28705408
[TBL] [Abstract][Full Text] [Related]
15. SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression.
Menderes G; Bonazzoli E; Bellone S; Black J; Altwerger G; Masserdotti A; Pettinella F; Zammataro L; Buza N; Hui P; Wong S; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2017 Jul; 146(1):179-186. PubMed ID: 28473206
[TBL] [Abstract][Full Text] [Related]
16. Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake.
Cheng Q; Wållberg H; Grafström J; Lu L; Thorell JO; Hägg Olofsson M; Linder S; Johansson K; Tegnebratt T; Arnér ES; Stone-Elander S; Ahlzén HS; Ståhl S;
EJNMMI Res; 2016 Dec; 6(1):58. PubMed ID: 27388754
[TBL] [Abstract][Full Text] [Related]
17. Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance.
Ranjbar R; Nejatollahi F; Nedaei Ahmadi AS; Hafezi H; Safaie A
Iran J Cancer Prev; 2015 Aug; 8(4):e3428. PubMed ID: 26478789
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenografts.
Wang S; Han X; Wang J; Yao J; Shi Y
PLoS One; 2014; 9(3):e89848. PubMed ID: 24595136
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant
Malecki M; Dahlke J; Haig M; Wohlwend L; Malecki R
J Genet Syndr Gene Ther; 2013 Jul; 4(6):152. PubMed ID: 24587967
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
